A Conditional Marketing Authorization is not an Emergency Use Authorization. The European Medicines Agency even explain this.
Please provide a citation for this claim. My reading of the EMA page for Conditional Marketing Authorization states: "Its use is also intended for a public health emergency (e.g. a pandemic). _For these medicines, less comprehensive pharmaceutical and non-clinical data may also be accepted_".
The fact that less comprehensive farmaceutical data is accepted for CMA leads me to believe they are experimental.
https://ec.europa.eu/commission/presscorner/detail/en/qanda_... (this is from the EC, not as I remembered the EMA)
It explains amongst other things that a Conditional Marketing Authorisation (CMA) is a real, controlled and robust, authorisation of the vaccine; this is unlike the Emergency Use Authorisation (EUA), which is really an authorisation of the use of an unauthorised vaccine.
A CMA requires data on safety and efficacy, showing the benefits outweigh the risks. An EUA has no such requirement.